About Transcriptomics and its Types
Transcriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of organism. A transcriptome represents the set of all RNA molecules, which is a small part of the genetic code. The variation in genetic expression characterizes the extensive range of physical and biochemical differences among various cells and tissues and may lead to disease. It helps researchers to understand transcriptional activity in disease cause. Transcriptomics includes four prominent technologies: Microarrays, PCR, RNAi Gene Silencing Technology, and NGS technologies.
TechNavio's analysts forecast the Global Transcriptomics market will grow at a CAGR of 15.8 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Transcriptomics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used for research and diagnostics. The products employed in the use microarray, PCR, NGS and RNAi techniques are considered within the scope of the report.
TechNavio's report, the Global Transcriptomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Transcriptomics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Abbott Laboratories
• Affymetrix Inc.
• Agilent Technologies Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• Thermo Fisher Scientific Inc.
Other Prominent Vendors
• Biological Industries Ltd.
• Bio-Rad Laboratories Inc.
• Cytognomix Inc.
• Kreatech Inc.
• Molecular Devices LLC
• Oxford Gene Technology Ltd.
• Qiagen N. V.
• SciGene Corp.
• Sigma-Aldrich Co. LLC
Key Market Driver
• Advancement in Transcriptomics Technology
• For a full, detailed list, view our report
Key Market Challenge
• Unmet Technological Needs
• For a full, detailed list, view our report
Key Market Trend
• Comprehensive Focus on Drug Discovery and Disease Diagnosis
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
More Information about Transcriptomics
•
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
08. Market Segmentation by Technology
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers, Acquisitions and Contracts
17.2 Vendor Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Laboratories
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2012
18.1.4 Business Segmentation by Revenue 2011 and 2012
18.1.5 Sales by Geography
18.1.6 Business Strategy
18.1.7 Key Developments
18.1.8 SWOT Analysis
18.1.9 Strengths
18.1.10 Weakness
18.1.11 Opportunities
18.1.12 Threats
18.2 Affymetrix Inc.
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Business Segmentation by Revenue 2013
18.2.5 Business Segmentation by Revenue 2012 and 2013
18.2.6 Sales by Geography
18.2.7 Business Strategy
18.2.8 Key Information
18.2.9 SWOT Analysis
18.2.10 Strengths
18.2.11 Weaknesses
18.2.12 Opportunities
18.2.13 Threats
18.3 Agilent Technologies Inc.
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Sales by Geography
18.3.6 Business Strategy
18.3.7 Key Information
18.3.8 SWOT Analysis
18.3.9 Strengths
18.3.10 Weaknesses
18.3.11 Opportunities
18.3.12 Threats
18.4 Illumina Inc.
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation
18.4.4 Sales by Geography
18.4.5 Business Strategy
18.4.6 Key Information
18.4.7 SWOT Analysis
18.4.8 Strengths
18.4.9 Weaknesses
18.4.10 Opportunities
18.4.11 Threats
18.5 F. Hoffmann La Roche Ltd.
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation
18.5.4 Business Segmentation by Revenue 2012 and 2013
18.5.5 Sales by Geography
18.5.6 Business Strategy
18.5.7 Key Information
18.5.8 SWOT Analysis
18.5.9 Strengths
18.5.10 Weaknesses
18.5.11 Opportunities
18.5.12 Threats
18.6 Thermo Fisher Scientific Inc.
18.6.1 Key Facts
18.6.2 Business Overview
18.6.3 Business Segmentation by Revenue
18.6.4 Product Segmentation by Revenue
18.6.5 Sales by Geography
18.6.6 Business Strategy
18.6.7 Key Information
18.6.8 SWOT Analysis
18.6.9 Strengths
18.6.10 Weaknesses
18.6.11 Opportunities
18.6.12 Threats
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Transcriptomics Market 2013-2018 (US$ million)
Exhibit 3: Global Transcriptomics Market by Application
Exhibit 4: Global Transcriptomics Market by Technology 2013
Exhibit 5: Global Transcriptomics Market Segmentation by Technology 2013
Exhibit 6: Global Transcriptomics Market by Geographical Segmentation 2013
Exhibit 7: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 8: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 9: Abbott Laboratories: Sales by Geography 2012
Exhibit 10: Affymetrix Inc.: Business Segmentation 2013
Exhibit 11: Affymetrix, Inc. 2013: Business Segmentation by Revenue 2013
Exhibit 12: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013(US$ million)
Exhibit 13: Affymetrix Inc.: Sales by Geography 2013
Exhibit 14: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
Exhibit 15: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 16: Agilent Technologies Inc.: Sales by Geography 2013
Exhibit 17: Illumina Inc.: Business Segmentation 2013
Exhibit 18: Illumina Inc.: Sales by Geography 2013
Exhibit 19: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 20: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013
Exhibit 21: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 22: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)
Exhibit 23: Thermo Fisher Scientific Inc.: Business Segmentation by Revenue 2013
Exhibit 24: Thermo Fisher Scientific Inc.: Product Segmentation by Revenue 2013
Exhibit 25: Thermo Fisher Scientific Inc.: Sales by Geography 2013
